Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesTransplantation, AutologousWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningTissue DonorsGraft SurvivalTransplantation ChimeraHematopoietic Stem CellsHistocompatibility TestingBone Marrow PurgingBone Marrow DiseasesHistocompatibilityBusulfanBone Marrow ExaminationBone RemodelingImmunosuppressive AgentsHematopoiesisTransplantation, IsogeneicKidney TransplantationHematologic NeoplasmsCyclophosphamideLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLRecurrenceBone Marrow NeoplasmsCytomegalovirus InfectionsRadiation ChimeraLiver TransplantationGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsImmunosuppressionTreatment OutcomeCombined Modality TherapyCyclosporineHepatic Veno-Occlusive DiseaseAcute DiseaseBone DensityGraft vs Host ReactionLymphocyte DepletionLeukemia, MyeloidRemission InductionRetrospective StudiesColony-Forming Units AssayHLA AntigensLymphoma, Non-HodgkinSurvival AnalysisHematologic DiseasesT-LymphocytesMyelodysplastic SyndromesOpportunistic InfectionsImmunocompromised HostNuclear FamilyLeukocyte TransfusionBone ResorptionChimeraTransplantation ImmunologySevere Combined ImmunodeficiencyHeart TransplantationStem Cell TransplantationFatal OutcomeCell DifferentiationLymphocyte TransfusionActuarial AnalysisLeukocyte CountFollow-Up StudiesSurvival RateSpleenFlow CytometryLung TransplantationAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred BALB CCells, CulturedDisease-Free SurvivalBone NeoplasmsPancytopeniaMultiple MyelomaCytomegalovirusAntilymphocyte SerumAntigens, CD34Granulocyte Colony-Stimulating FactorPneumonia, ViralBlood Group IncompatibilityInfectionMycosesGraft vs Tumor EffectGranulocytesHodgkin DiseasePolymerase Chain ReactionMice, KnockoutBone Development